| Literature DB >> 29348163 |
W Greg Miller1, Heinz Schimmel2, Robert Rej3, Neil Greenberg4, Ferruccio Ceriotti5, Chris Burns6, Jeffrey R Budd7, Cas Weykamp8, Vincent Delatour9, Göran Nilsson10, Finlay MacKenzie11, Mauro Panteghini12, Thomas Keller13, Johanna E Camara14, Ingrid Zegers2, Hubert W Vesper15.
Abstract
Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by ≥2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.Entities:
Mesh:
Year: 2018 PMID: 29348163 PMCID: PMC5832613 DOI: 10.1373/clinchem.2017.277525
Source DB: PubMed Journal: Clin Chem ISSN: 0009-9147 Impact factor: 8.327